Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Non-Inferiority Trial on the Efficacy of CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias

NCT07073742 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT07073742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07073742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Non-Inferiority Trial on the Efficacy of CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias
Lead sponsor
Charles University, Czech Republic
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
September 1, 2028
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

reticular leg veins, spider veins, varicose veins of lower limb